Ozempic microdosing is gaining popularity but is it effective?

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.With approximately 70% of American adults meeting the criteria for being obese or overweight, more people are turning to weight loss medications to help them shed pounds.Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity.Both are made by Novo Nordisk.Eli Lilly also offers a diabetes medication, Mounjaro, as well as a version for weight loss, Zepbound.“Ozempic is the only version among the weekly injectables — Ozempic, Wegovy, Zepbound and Mounjaro — that has the option to ‘hack’ the pen for a smaller dose,” Dr.

Alexandra Sowa, an obesity medicine specialist and founder of SoWell in New York, told Fox News Digital.She is also the author of the book “The Ozempic Revolution” that is set to be released on Jan.7.Fox News Digital spoke to the experts to get the skinny on this latest trend.Microdosing Ozempic refers to using smaller amounts compared to the standard therapeutic doses that are traditionally prescribed for managing type 2 diabetes and aiding weight loss, experts say.This practice is not approved by the U.S.

Food and Drug Administration (FDA).“Health care clinicians do not typically recommend this approach, as the standard dosing regimen is based on clinical trials determining the most effective and safe amount for these conditions,” noted Dr.Fatima Cody Stanford, obesity medicine physician at Massachusetts General Hospital and Harvard Medical School.There are no established guidelines for microdosing – although there are reports on social media of using 10 to 100 times lower than standard prescriptions, added Dr.

Christopher McGowan, a gastroenterologist and obesity specialist who runs True You Weight Loss in Cary, North Carolina.Some people get confused by the terminology, the doctors noted.“I think there’s a little bit of a misconception, as some people say ‘I’...